AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17876174
Drug: Usual Care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual Care decision aid (previous digital rectal examination)
Trial: 11208880
Drug: Surgery, tamoxifen,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery, tamoxifen, and chemotherapy
Trial: 1515565
Drug: Propranolol 40
RxNorm normalized name: propranolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 40 mg per os
Trial: 6540930
Drug: Conventional palliative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional palliative regimen without corticoid therapy
Trial: 19597011
Drug: Maternal and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal and infant antiretroviral therapy, elective cesarean section, avoidance of breast-feeding
Trial: 19597011
Drug: Unmet need
RxNorm normalized name: diphenhydramine
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unmet need for antiretroviral therapy
Trial: 11172505
Drug: Triple-injection method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-injection method (group III) - ulnar nerve not located
Trial: 11172505
Drug: Four-injection method
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four-injection method (group IV) - all nerves located
Trial: 28089080
Drug: Salba‐chia (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salba‐chia (30 g/1000 kcal/day)
Trial: 28089080
Drug: Oat bran-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oat bran-based control (36 g/1000 kcal/day)
Trial: 21269346
Drug: Weekly Unna
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly Unna boot therapy
Trial: 10705939
Drug: Duration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duration of symptoms, type of gamma‐camera or radiopharmaceutical agent used.
Trial: 9493655
Drug: Zileuton (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zileuton (400 mg)
Trial: 19882857
Drug: Standard complex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard complex therapy without UVABI
Trial: 14510038
Drug: Limited case
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Limited case management services from primary drug counselors
Trial: 14510038
Drug: Other drug
RxNorm normalized name: Other drugs for bile therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other drug use
Trial: 9339804
Drug: Ciprofloxacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (200 microg/ml), 5 drops three times a day for 10 days
Trial: 9339804
Drug: Gentamicin sulfate
RxNorm normalized name: Gentamicin Sulfate
DrugBank: Gentamicin (DB00798)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gentamicin sulfate (5 mg/ml), 5 drops three times a day for 10 days
Trial: 2412037
Drug: Ketanserin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (20 mg, b.i.d. for 2 weeks, then doubled)
Trial: 2412037
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 mg, b.i.d. for 2 weeks, then doubled)
Trial: 30160787
Drug: 2% tofacitinib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% tofacitinib ointment applied twice daily
Trial: 30160787
Drug: 1% ruxolitinib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% ruxolitinib ointment
Trial: 30160787
Drug: Topical clobetasol
RxNorm normalized name: clobetasol Topical Foam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical clobetasol dipropionate 0.005% ointment
Trial: 23900641
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg of L‐3,4‐dihydroxyphenylalanine (L‐DOPA)
Trial: 16860613
Drug: AGA II
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AGA II compared to antitissue transglutaminase antibodies
Trial: 10870980
Drug: SK and
RxNorm normalized name: Ispaghula husk and mebeverine only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SK and F 107647 (1, 10, 100, 500, and 1000 μg/kg as single 15-minute iv infusion)
Trial: 10870980
Drug: SK and
RxNorm normalized name: Ispaghula husk and mebeverine only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SK and F 107647 (0.001, 0.01, 0.1 and 1 μg/kg as 2-hour iv infusions once daily for 10 days)
Trial: 1900978
Drug: Flecainide 150
RxNorm normalized name: flecainide 150 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flecainide 150 mg twice per day for 3 months
Trial: 25450717
Drug: Tenofovir alafenamide
RxNorm normalized name: Tenofovir Alafenamide
DrugBank: Tenofovir alafenamide (DB09299)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tenofovir alafenamide 8 mg
Trial: 28369415
Drug: Tenofovir alafenamide
RxNorm normalized name: Tenofovir Alafenamide
DrugBank: Tenofovir alafenamide (DB09299)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tenofovir alafenamide 25 mg
Trial: 25450717
Drug: Tenofovir alafenamide
RxNorm normalized name: Tenofovir Alafenamide
DrugBank: Tenofovir alafenamide (DB09299)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tenofovir alafenamide 40 mg
Trial: 25450717
Drug: Tenofovir alafenamide
RxNorm normalized name: Tenofovir Alafenamide
DrugBank: Tenofovir alafenamide (DB09299)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tenofovir alafenamide 120 mg
Trial: 28404092
Drug: Tenofovir disoproxil
RxNorm normalized name: Tenofovir Disoproxil
DrugBank: Tenofovir disoproxil (DB00300)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tenofovir disoproxil fumarate 300 mg
Trial: 9208343
Drug: Maalox 70
RxNorm normalized name: Maalox
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maalox 70 suspension (10 ml) with cerivastatin (200 micrograms)
Trial: 9208343
Drug: Cimetidine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (400 mg b.i.d. for 4 days) with cerivastatin (200 micrograms)
Trial: 7708405
Drug: Nasal capsaicin
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nasal capsaicin treatment on the ipsilateral side
Trial: 7708405
Drug: Nasal capsaicin
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nasal capsaicin treatment on the contralateral side
Trial: 7708405
Drug: Nasal capsaicin
RxNorm normalized name: Capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nasal capsaicin treatment for chronic patients (ipsilateral and contralateral alternately)
Trial: 7708405
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of ipsilateral vs contralateral treatment
Trial: 3616278
Drug: Single-dose trimethoprim
RxNorm normalized name: Trimethoprim
DrugBank: Trimethoprim (DB00440)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose trimethoprim 400 mg once
Trial: 3616278
Drug: Multi-dose trimethoprim
RxNorm normalized name: VIAL ADAPTER MULTI-DOSE ALARIS #2205E
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-dose trimethoprim 200 mg twice daily for five days
Trial: 26892939
Drug: High-dose unilateral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose unilateral ECT
Trial: 20299496
Drug: triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: triple therapy including lopinavir/ritonavir
Trial: 12517650
Drug: Intraabdominal irrigation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraabdominal irrigation with normal saline (500-1000 mL)
Trial: 10769584
Drug: Ramipril at
RxNorm normalized name: Ramipril
DrugBank: Ramipril (DB00178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ramipril at a dose of 10 mg/day
Trial: 10769584
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E supplements at a dose of 400 UI/day
Trial: 8804873
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (colloidal bismuth subcitrate 480 mg/day plus metronidazole 750 mg/day and tetracycline 1000 mg/day for 4 weeks)
Trial: 12360598
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg/day for 8 weeks
Trial: 6496919
Drug: Heparin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin + 1000 units of purified human antithrombin III (AT III) concentrate
Trial: 1497392
Drug: Heparin only
RxNorm normalized name: Heparin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin only
Trial: 28527204
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose LEV (2.5 mg/kg)
Trial: 28527204
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose LEV (7.5 mg/kg)
Trial: 26097215
Drug: Abatacept (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abatacept (10 mg/kg every 4 weeks)
Trial: 24199969
Drug: Qigong training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qigong training (twice a week for 10 weeks)
Trial: 21891890
Drug: HA+200 μg
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: HA+200 μg drug solution of ALN
Trial: 19696601
Drug: Individualized Acu/Moxa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized Acu/Moxa treatment
Trial: 12943880
Drug: Jo heparin‐coated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jo heparin‐coated stent deployment
Trial: 1632658
Drug: Piroxicam 20
RxNorm normalized name: piroxicam 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam 20 mg/day by mouth
Trial: 6489428
Drug: Acetaminophen 12‐14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 12‐14 mg/kg
Trial: 6489428
Drug: Acetaminophen 22‐27
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 22‐27 mg/kg
Trial: 6489428
Drug: Acetaminophen repeated
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen repeated doses every 4 or 8 h for 1 to 3 days
Trial: 6489428
Drug: Acetaminophen repeated
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen repeated doses
Trial: 29020483
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT), applied three times weekly.
Trial: 20713433
Drug: Broccoli intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broccoli intake (250 g/day)
Trial: 17553051
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of amorolfine hydrochloride 5% nail lacquer once weekly for 12 months plus terbinafine 250 mg once daily for 3 months (AT group)
Trial: 17553051
Drug: Terbinafine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine alone once daily for 3 months (T group)
Trial: 12117037
Drug: Airmax inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Airmax inhaler at fast flow rate (60 l min(‐1))
Trial: 12117037
Drug: Turbuhaler at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Turbuhaler at fast flow rate (60 l min(‐1))
Trial: 12117037
Drug: Airmax inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Airmax inhaler at slow flow rate (30 l min(‐1))
Trial: 12117037
Drug: Turbuhaler at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Turbuhaler at slow flow rate (30 l min(‐1))
Trial: 12117037
Drug: pMDI at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pMDI at slow flow rate (30 l min(‐1))
Trial: 7487784
Drug: Psychiatric case
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psychiatric case management using an assertive community treatment model involving general practitioners
Trial: 2151518
Drug: Domperidone (DMP;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (DMP; 20 mg orally)
Trial: 7422533
Drug: Oral pentaerythritol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral pentaerythritol tetranitrate
Trial: 7422533
Drug: Oral pentaerythritol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral pentaerythritol tetranitrate (high dosage)
Trial: 21297567
Drug: BCAA (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAA (300 mg . kg . day ‐1)
Trial: 10406241
Drug: ASA/PC (Aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA/PC (Aspirin associated with phosphatidylcholine)
Trial: 10406241
Drug: ASA (Aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASA (Aspirin alone)
Trial: 26022813
Drug: Dalcetrapib (a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalcetrapib (a cholesteryl ester transfer protein inhibitor)
Trial: 10430816
Drug: Oral antihyperglycemic
RxNorm normalized name: ANTIHYPOGLYCEMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antihyperglycemic agents
Trial: 7558380
Drug: Testosterone enanthate,
RxNorm normalized name: Testosterone Enanthate, enanthate 200 mg/mL intramuscular solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate, 200 mg IM, weekly injections during the suppression (6‐month) and efficacy (12‐month) phases.
Trial: 496621
Drug: 1000‐IU vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000‐IU vitamin E capsules (alpha‐tocopherol) administered daily for 28 days
Trial: 496621
Drug: 1000‐IU vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000‐IU vitamin E capsules (alpha‐tocopherol)
Trial: 30650245
Drug: Group-based mindfulness-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-based mindfulness-based cognitive therapy (MBCT)
Trial: 28574379
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy for DFS
Trial: 28574379
Drug: Cytoflavin 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytoflavin 10 ml 0.9% NaCl 200 ml for 10 days, followed by 2 tablets 2 times per day orally for one month
Trial: 25029675
Drug: Multi-ingredient supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-ingredient supplement enriched with l-glutamine and l-carnitine-l-tartrate
Trial: 25029675
Drug: Carbohydrate supplement
RxNorm normalized name: carbohydrate supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate supplement
Trial: 25029675
Drug: Multi-ingredient supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multi-ingredient supplement
Trial: 19056578
Drug: Glutamine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glutamine (30 g)
Trial: 17242107
Drug: Conventional catheter
RxNorm normalized name: CATHETER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional catheter (CC group)
Trial: 12475466
Drug: Carvedilol (0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (0.01 mg/kg/day titrated up to 0.2 mg/kg/day)
Trial: 9535429
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg aspirin daily
Trial: 9535429
Drug: Felodipine 5
RxNorm normalized name: felodipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 5 mg daily
Trial: 7608438
Drug: L-carnitine (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (9 g/day intravenously for the first 5 days, then 6 g/day orally for 12 months)
Trial: 23958241
Drug: Pioglitazone, 45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone, 45 mg/d for 6 months
Trial: 23958241
Drug: Metformin, 2
RxNorm normalized name: Glipizide-Metformin, 2.5 mg-250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin, 2 g/day added after pioglitazone
Trial: 15236870
Drug: Chemoradiation to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoradiation to a total dose of 50.4Gy (1.8Gy per fraction) with two courses of bolus 5-fluorouracil and leucovorin
Trial: 11736860
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg diazepam i.n.
Trial: 11736860
Drug: 7 mg
RxNorm normalized name: pectin 7 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 mg diazepam i.n.
Trial: 11736860
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg intravenous diazepam
Trial: 8214649
Drug: Propofol 1-2
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol 1-2 mg/kg for induction and sufentanil 0.03 micrograms.kg-1.min-1 plus propofol 50-200 micrograms.kg-1.min-1 for maintenance (Group A)
Trial: 22661750
Drug: Low tidal
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low tidal volume ventilation (6 ml kg(‐1) predicted body weight)
Trial: 22661750
Drug: High tidal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High tidal volume ventilation (12 ml kg(‐1) predicted body weight)
Trial: 20200338
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg ibudilast
Trial: 20200338
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg ibudilast
Trial: 20200338
Drug: Ibudilast (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibudilast (both doses)
Trial: 12919884
Drug: Extracorporeal shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shock wave therapy (ESWT) at 0.12 mJ/mm(2)
Trial: 10329871
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered misoprostol (50 micrograms every 4 hours)
Trial: 10329871
Drug: Vaginally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginally administered misoprostol (25 micrograms every 4 hours)
Trial: 10329871
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered misoprostol
Trial: 21644418
Drug: Vaginally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginally administered misoprostol
Trial: 2007107
Drug: 3.75 mg
RxNorm normalized name: zopiclone 3.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.75 mg hyperbaric bupivacaine
Trial: 18070995
Drug: Losartan-based antihypertensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan-based antihypertensive therapy
Trial: 22070095
Drug: Atenolol-based antihypertensive
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol-based antihypertensive therapy
Trial: 15548795
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy plus 2.5% povidone‐iodine every 2 hours for 2 weeks
Trial: 9625084
Drug: Parents as
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parents as agents of change (experimental group)
Trial: 9625084
Drug: Children as
RxNorm normalized name: AZELASTINE HYDROCHLORIDE 205.5 ug NASAL SPRAY, METERED [Children Astepro Allergy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Children as agents of change (control group)
Trial: 17212003
Drug: Interferon alpha
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha ‐ 2b (Intron‐A) 3 million units (MU) subcutaneously thrice weekly for 6 months
Trial: 21416235
Drug: Ningdong granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ningdong granule (NDG) 5 mg/kg/day
Trial: 7851625
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 131I adjusted to the patients' thyroid weight (group 1)
Trial: 7851625
Drug: Repeated lower
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated lower dose of 131I (approximately 30Gy) (group 2)
Trial: 61564
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of urea, saline, and sodium bicarbonate; oral water load
Trial: 31606448
Drug: Transcranial direct
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial direct current stimulation (tDCS) 20-min daily stimulation
Trial: 31606448
Drug: Transcranial direct
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transcranial direct current stimulation (tDCS) 2×20-min daily stimulation
Trial: 25823271
Drug: Psychotherapy in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotherapy in addition to medical therapy
Trial: 25823271
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy only (Control Group 2)
Trial: 15104658
Drug: Granulocyte apheresis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte apheresis (GA-1) after initial mobilization with glycosylated G-CSF 6.0 micro g per kg and oral dexamethasone (DXM, 8 mg)
Trial: 15104658
Drug: Remobilization with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remobilization with DXM 8 mg
Trial: 15104658
Drug: Remobilization with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remobilization with DXM 4 mg